6岁以下儿童急性意外摄入甲氨蝶呤后的毒性评估:一项16年多中心回顾性研究
本研究为美国6个中毒中心16年回顾性队列,纳入103例6岁以下儿童急性意外摄入甲氨蝶呤病例。84%病例报告了剂量,范围1.3–75 mg,97%摄入剂量≤20 mg。96%(99/103)无临床效应,3例(3%)为轻微结局,无重大结局或死亡。作者认为单次急性摄入≤20 mg时居家观察、不转诊、不用甲氨蝶呤特异性治疗是合理的。
要点
- 103例6岁以下儿童急性意外摄入甲氨蝶呤,97%摄入剂量≤20 mg,96%(99/103)无临床效应。
- 3例(3%)出现轻微结局,无重大结局或死亡。
- 84%(86/103)报告了剂量,范围1.3–75 mg。
- 作者认为急性摄入≤20 mg可居家观察,无需转诊或甲氨蝶呤特异性治疗。
适用人群与场景
- 美国6个中毒中心报告的6岁以下儿童急性意外无监督摄入甲氨蝶呤病例。
处置流程与药物剂量
- 作者认为,急性摄入≤20 mg的患儿可居家观察,无需转诊至医院,也无需甲氨蝶呤特异性治疗。
研究设计与关键结果
- 回顾性队列研究,纳入103例6岁以下儿童急性意外摄入甲氨蝶呤病例,来自美国6个中毒中心,时间跨度16年。
- 86例(84%)报告了甲氨蝶呤剂量,范围为1.3–75 mg;97%的病例摄入剂量≤20 mg。
- 99/103例(96%)无临床效应;3例(3%)为轻微结局;无重大结局或死亡。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于6岁以下儿童单次急性意外摄入甲氨蝶呤≤20 mg,居家观察而不转诊、不使用甲氨蝶呤特异性治疗是合理的。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: There is little data on the frequency of adverse events following acute methotrexate ingestions in pediatric patients. Likewise, recommendations for observation length, site and management strategies in this population are not well established. Therefore, most recommendations are modeled after management of chronic overdose in patients with underlying medical conditions.
OBJECTIVE: The primary objective of this study is to determine the frequency of acute toxicity after acute methotrexate accidental unsupervised ingestions in patients less than six years. In addition, we describe the frequency of late toxicity and characterize the management site and approaches.
MATERIALS AND METHODS: This is a retrospective cohort study of pediatric accidental unsupervised methotrexate ingestions reported to six poison centers in the United States over a 16 year period. Demographic information, exposure details, signs, symptoms, treatments, length and location of observation and outcomes were collected.
RESULTS: 103 patients met inclusion criteria. Methotrexate dose was reported in 86 patients (84%) and ranged from 1.3 mg-75 mg. The majority of cases (97%) ingested a dose ≤20 mg. The significant majority of cases experienced no clinical effects (99 of 103 cases; 96%). Three children experienced minor outcome (3%). There were no patients with a major outcome or death.
CONCLUSIONS: The incidence of toxicity from pediatric single, acute ingestions of methotrexate is rare and when it occurs is generally limited to no or only minimally concerning effects. Because concentrations from single ingestions were consistent with low subtoxic exposures, we believe that home monitoring without hospital referral and without methotrexate specific therapy is reasonable in those with acute ingestions up to 20 mg.
参考来源
- Hays H, Beuhler MC, Spiller HA, et al. Evaluation of toxicity after acute accidental methotrexate ingestions in children under 6 years old: a 16-year multi-center review. Clin Toxicol (Phila). 2017. PMID: 28730845. doi:10.1080/15563650.2017.1349319
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。